Skip to main content


You are viewing the new article page. Let us know what you think. Return to old version

Oral presentation | Open | Published:

Therapeutic considerations in the treatment of major psychiatric disorders

The pharmacological treatment of major psychiatric disorders is based on antipsychotic medication (for schizophrenia and manic episodes of mood disorders) and on antidepressants (for the depressive episodes of mood disorders). The main pharmacotherapeutic considerations concern efficacy, side-effects and tolerability. These issues are related to pharmacodynamic and pharmacokinetic characteristics of the various medications such as the affinity to various receptors, selectivity to those which are most relevant in the pathophysiology of the disorders, and drug half life. These qualities are associated to the optimum daily dosing, dose regimen and the mode of escalation of the doses of each drug, as well as to its side-effect profile. These issues will be discussed for antipsychotics and antidepressants, in a practical manner, together with general issues in pharmacotherapy related to polypharmacy and combinations with other drug classes, whenever this is appropriate.

Author information

Correspondence to Dimitrios Dikaios.

Rights and permissions

Reprints and Permissions

About this article


  • Public Health
  • Schizophrenia
  • Psychiatric Disorder
  • Pharmacological Treatment
  • Dose Regimen